CALA - Calithera Biosciences

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

CALA - Calithera Biosciences

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Tue 14'th Aug 2018

PERIOD 2018-05-15 - 2018-08-14
CHANGE 2.59%
PRICE $4.75





Request Prediction

Calithera Biosciences Stock Analysis

Technical stock analysis for Tue 14'th Aug 2018

Buy candidate since 2018-08-14
Shorts 3.42% ( 2018-07-31 )
Cash 165.6 mill
Loans n/a
Beta 2.38
ROA -17.87

Calithera Biosciences gained 2.59% in the last trading day, rising from $4.63 to $4.75 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a 6.74% gain for the last 2 weeks. Volume fell in the last day by -107 892 shares, and in total, 263 108 shares bought and sold for approximately $1.25 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.


Calithera Biosciences lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.79% during the next 3 months and, with 90% probability hold a price between $3.19 and $4.14 at the end of this period.

Click here for today's Top 5 Trending Companies


Calithera Biosciences holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $4.59 and $4.65. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday August 10, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 56 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Calithera Biosciences finds support from accumulated volume at $4.53.

Support: $4.53 Price: $4.75 Resistance: $5.20


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.15 between high and low, or 3.26%. For the last week the stock has had a daily average volatility of 9.41%.

Our recommended stoploss: $4.56 (-3.92%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High


Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.

Buy Candidate

Click for Top 5 Buy Candidates
CALA $4.75 $0.12(2.59%)
CALA is up $0.12 today, but where's it headed in September?
Zacks Investment Research is releasing its prediction for CALA based on the 1-3 month system that more than doubles the S&P 500.

Click here – the CALA analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with